Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …

Objective: The prevalence of hyperprolactinemia in non-functioning pituitary
macroadenomas (NFPMAs) is not well known, and hyperprolactinemia caused by a NFPMA …

Objective Hyperprolactinemia in patients with nonfunctioning pituitary adenomas (NFPAs)
has been explained by the stalk compression of large pituitary adenomas. However, not all …

Abstract Tjeerdsma G, Sluiter WJ, Hew JM, Molenaar WM, de Lange WE, Dullaart RPF.
Hyperprolactinaemia is associated with a higher prevalence of pituitary—adrenal …

Objective: Serum PRL levels at presentation may be useful in distinguishing between
disconnection hyperprolactinemia in non-secretory pituitary adenomas and prolactinomas in …

Clinically nonfunctioning pituitary adenomas (NFPA) are the most common pituitary tumors
after prolactinomas. The absence of clinical symptoms of hormonal hypersecretion can …

Purpose The aim of this study was to assess clinical features and therapeutic outcomes in
patients with clinically non-functioning pituitary macroadenomas (NFPMAs). Method This is …

Introduction Usually, prolactinomas are treated with dopamine agonists (DA). Surgery is
considered an option when the patient cannot bear or does not respond positively to DA …

The objective of this study was to evaluate characteristics that discriminate prolactinoma
from non-functioning pituitary macroadenoma with hyperprolactinemia. We included 117 …

Purpose Non-functioning pituitary adenomas (NFPAs) are often associated with
hyperprolactinemia, which is known as the “stalk effect”. However, the relationships between …